Search Within

Ayca Gucalp

Formats
  1. Meeting Abstract (72)
  2. Journal Article (37)
  3. Book Section (3)
  4. Review (1)
Groups
  1. Breast Medicine Service (113)
  2. Department of Medicine (113)
  3. Solid Tumor Oncology Division (113)
  4. Survivorship Research (92)
  5. Population Sciences Research Program (49)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. Tiffany Traina (59)
  2. Clifford Hudis (48)
  3. Neil Iyengar (29)
  4. Sujata Patil (24)
  5. Dilip Giri (20)
  6. Monica Morrow (15)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer Research (23)
  3. Annals of Oncology (7)
  4. Breast Cancer Research and Treatment (5)
  5. Clinical Cancer Research (4)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. American Association for Cancer Research (29)
  3. Springer (11)
  4. Oxford University Press (9)
  5. Elsevier Inc. (8)
  6. Wiley Blackwell (3)

More Publishers

Results (113)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Men with advanced breast cancer (BC): Initial phase (Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor
    Meeting Abstract

    Elias, A.; Gucalp, A.; Bardia, A.; Resaul, A.; Eisner, J.; Baskin-Bey, E.; Traina, T. A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer
    Meeting Abstract

    Ho, A.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B.; Patil, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Quantifying the incidence of homologous recombination repair status in metastatic triple negative breast cancer receiving concurrent cisplatin and radiation therapy
    Meeting Abstract

    Powell, S. N.; Gucalp, A.; Traina, T. A.; Patil, S.; Wilgucki, M.; Arnold, B. B.; Cahlon, O.; Delsite, R.; Ulaner, G. A.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Periprostatic adipose inflammation is associated with high-grade prostate cancer
    Journal Article

    Gucalp, A.; Iyengar, N. M.; Zhou, X. K.; Giri, D. D.; Falcone, D. J.; Wang, H.; Williams, S.; Krasne, M. D.; Yaghnam, I.; Kunzel, B.; more...
    Prostate Cancer and Prostatic Diseases (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B. B.; Zhang, Z.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The androgen receptor: Is it a promising target?
    Journal Article

    Gucalp, A.; Traina, T. A.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy-associated nail disease in cancer patients
    Meeting Abstract

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of Investigative Dermatology (2017)

    Fulltext@MSK | Save
  • A phase I/Ib study of enzalutamide alone and in combination with endocrine therapies in women with advanced breast cancer
    Journal Article

    Schwartzberg, L. S.; Yardley, D. A.; Elias, A. D.; Patel, M.; LoRusso, P.; Burris, H. A.; Gucalp, A.; Peterson, A. C.; Blaney, M. E.; Steinberg, J. L.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save